Serina Therapeutics (SER) Revenue (2018 - 2025)
Serina Therapeutics (SER) posted Revenue of $130000.0 for Q2 2025, up 1028.57% sequentially from -$14000.0 in Q4 2024, and up 154.9% YoY from $51000.0 in Q2 2024.
Serina Therapeutics (SER) Revenue (2018 - 2025) Analysis & Trends
Serina Therapeutics has reported Revenue for 8 years, with the latest figure at $130000.0 in Q2 2025.
- Quarterly Revenue rose 154.9% year-over-year to $130000.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $130000.0 (up 132.14% YoY) and the FY2025 annual result came in at $130000.0, up 132.14% from the prior year.
- Revenue grew to $130000.0 in Q2 2025 per SER's latest filing, from -$14000.0 in the prior quarter.
- Over five years, Revenue peaked at $3.1 million in Q4 2023 and troughed at -$14000.0 in Q4 2024.
- A 5-year average of $214705.9 and a median of $24000.0 in 2021 frame the typical range for Revenue.
- The sharpest annual moves came in 2023 and 2024: Revenue soared 38487.5% in 2023, then plunged 100.45% in 2024.
- Over 5 years, Revenue stood at $160000.0 in 2021, then tumbled by 95.0% to $8000.0 in 2022, then jumped by 38487.5% to $3.1 million in 2023, then sank by 100.45% to -$14000.0 in 2024, then jumped by 1028.57% to $130000.0 in 2025.
- According to Business Quant data, Revenue over the past three periods registered $130000.0, -$14000.0, and $14000.0 for Q2 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Serina Therapeutics | 43.17 Mn | 20.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 130,000.00 |
| Dec 31, 2024 | -14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 3.09 Mn |
| Sep 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 160,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Mar 31, 2021 | 56,000.00 |
| Dec 31, 2020 | 158,000.00 |
| Sep 30, 2020 | 69,000.00 |
| Jun 30, 2020 | 45,000.00 |